Malignant Neoplasm of Stomach Not Yet Recruiting Phase 2 Trials for Trastuzumab (DB00072)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03950271SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction AdenocarcinomaTreatment